SCHEMBL5219974

SCHEMBL5219974

O=C(O)c1c(S(=O)(=O)N2CCOCC2)c2ccccc2n1Cc1ccc(Cl)c(Cl)c1

nearest known ligand 0.63

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 12/20 0.63
ALDH1A1 P00352 2/20 0.47
LMNA P02545 2/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
POLB P06746 2/20 0.47
KDM4E B2RXH2 1/20 0.47
USP2 O75604 1/20 0.47
ABCB11 O95342 1/20 0.46
MAPT P10636 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
HPGD P15428 1/20 0.46
CYP2C19 P33261 1/20 0.46
HTT P42858 1/20 0.45
PIK3C2B O00750 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5220401 0.88 CCR2 (0.61) CCR2ALDH1A1LMNAMEN1KMT2A
SCHEMBL5220393 0.88 CCR2 (0.61) CCR2ALDH1A1LMNAMEN1KMT2A
SCHEMBL5215970 0.87 CCR2 (0.50) CCR2ALDH1A1LMNAMEN1KMT2A
SCHEMBL7467238 0.84 CCR2 (0.58) CCR2ALDH1A1LMNAMEN1KMT2A
SCHEMBL6902224 0.82 CCR2 (0.67) CCR2ALDH1A1LMNAMEN1KMT2A
SCHEMBL5216530 0.81 CCR2 (0.68) CCR2ALDH1A1LMNAMEN1KMT2A
SCHEMBL6599738 0.78 CCR2 (1.00) CCR2ALDH1A1LMNAMEN1KMT2A
SCHEMBL6302591 0.77 CCR2 (1.00) CCR2ALDH1A1LMNAMEN1KMT2A
SCHEMBL5214833 0.76 CCR2 (0.48) CCR2ALDH1A1LMNAMEN1KMT2A
SCHEMBL5214826 0.76 CCR2 (0.48) CCR2ALDH1A1LMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1173421-B1 INDOLE DERIVATIVES AS ANTI-INFLAMMATION AGENTS ASTRAZENECA AB (SE) 2007-10-03 EP disclosed
US-6833387-B1 3-substituted indoles; inhibition of monocyte chemoattractant protein-1 and/or RANTES induced chemotaxis; inflammatory diseases ASTRAZENECA AB (SE) 2004-12-21 US disclosed
EP-1173421-A2 INDOLE DERIVATIVES AS ANTI-INFLAMMATION AGENTS AstraZeneca AB (SE) 2002-01-23 EP disclosed
WO-2000046199-A2 INDOLE DERIVATIVES AS ANTI-INFLAMMATION AGENTS ASTRAZENECA AB (SE) 2000-08-10 WO disclosed